the dbcg trial 80-r2 is the largest randomized trial of caf ( cyclophosphamide , doxorubicin , 5-fluorouracil ) versus cmf ( cyclophosphamide , methotrexate , 5-fluorouracil ) in recurrent breast cancer .
C0950521
cmf
C0010583
cyclophosphamide